J Korean Rheum Assoc.  1994 Jul;1(2):239-243.

The Clinical Evaluation Of Eperisone Hydrochloride (Mulex)

Affiliations
  • 1Department of Orthopedic Surgery, School of Medicine, Kyung Hee University, Seoul, Korea.

Abstract

Conservative treatment is the main therapy for cervicobrachial syndrome, scapulohumeral periarthritis, and lumbago as diseases with both pain and myotonia. The-conservative treatment mainly consists of medication, physiotherapy, and kinesiotherapy. In the recent years, attempts have been made to give relief to myotonia through combination therapy with antiinflammatory analgesics and muscle relaxants. The muscle relaxants using in general are tolperisone hydrochloride, chlormezanone, and diazepam. Eperizone hydrochloride(Mulex tablet) is a beta-propriophenone derivatives and a central acting muscle relaxant, And it benefited subjective symptoms such as muscular pain (lumbago, neck pain) and a stiff muscle sensation (shoulder tension, tension feeling of lower limb). Among 22 patients, there were 14 lumbagos, two cephalobrachial syndromes, one scapulohumeral periarthritis, and five combined patients were chosen and duration of symptom was 5 years (3months-15years) in average. Mulex tablet was administered in a dose of 3 tablets (150rag) per day in 22 patients for 6 weeks prospectively. We analysed general improvement rating (GIR), general usefulness rating(GUR), and overall safety rating. The general improvement rate was 78% and the aggravation rate was 4%. The complication after, madication was infrequently gastrointestinal trouble. Incidence of side effect was 22%, but all these complications were insignificant. Hematology, blood chemistry, and urinalysis after medication were normal.

Keyword

Eperisone hydrochloride(Mulex); clinical study

MeSH Terms

Analgesics
Chemistry
Chlormezanone
Diazepam
Hematology
Humans
Incidence
Low Back Pain
Myotonia
Neck
Periarthritis
Prospective Studies
Sensation
Tablets
Tolperisone
Urinalysis
Analgesics
Chlormezanone
Diazepam
Tablets
Tolperisone
Full Text Links
  • JKRA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr